AT358168B - Verfahren zur herstellung von neuen substituierten n-methylenderivaten des thienamycins - Google Patents

Verfahren zur herstellung von neuen substituierten n-methylenderivaten des thienamycins

Info

Publication number
AT358168B
AT358168B AT863476A AT863476A AT358168B AT 358168 B AT358168 B AT 358168B AT 863476 A AT863476 A AT 863476A AT 863476 A AT863476 A AT 863476A AT 358168 B AT358168 B AT 358168B
Authority
AT
Austria
Prior art keywords
thienamycine
producing new
new substituted
methylene derivatives
methylene
Prior art date
Application number
AT863476A
Other languages
German (de)
English (en)
Other versions
ATA863476A (de
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Publication of ATA863476A publication Critical patent/ATA863476A/de
Application granted granted Critical
Publication of AT358168B publication Critical patent/AT358168B/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D477/00Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
    • C07D477/10Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C07D477/12Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6
    • C07D477/16Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6 with hetero atoms or carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 3
    • C07D477/20Sulfur atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D205/00Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/02Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D205/06Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D205/08Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02Silicon compounds
    • C07F7/08Compounds having one or more C—Si linkages
    • C07F7/10Compounds having one or more C—Si linkages containing nitrogen having a Si-N linkage

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
AT863476A 1975-11-21 1976-11-19 Verfahren zur herstellung von neuen substituierten n-methylenderivaten des thienamycins AT358168B (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US63429675A 1975-11-21 1975-11-21
US67626176A 1976-04-12 1976-04-12
US73365476A 1976-10-18 1976-10-18

Publications (2)

Publication Number Publication Date
ATA863476A ATA863476A (de) 1980-01-15
AT358168B true AT358168B (de) 1980-08-25

Family

ID=27417545

Family Applications (1)

Application Number Title Priority Date Filing Date
AT863476A AT358168B (de) 1975-11-21 1976-11-19 Verfahren zur herstellung von neuen substituierten n-methylenderivaten des thienamycins

Country Status (27)

Country Link
AT (1) AT358168B (fi)
AU (1) AU512383B2 (fi)
BG (1) BG34037A3 (fi)
CA (1) CA1083577A (fi)
CH (2) CH632510A5 (fi)
DD (1) DD127742A5 (fi)
DE (1) DE2652679A1 (fi)
DK (1) DK157401C (fi)
EG (1) EG12261A (fi)
ES (1) ES453501A1 (fi)
FI (1) FI62306C (fi)
FR (1) FR2332012A1 (fi)
GB (1) GB1570990A (fi)
GR (1) GR62072B (fi)
HK (1) HK29683A (fi)
HU (1) HU180865B (fi)
IE (1) IE44433B1 (fi)
IL (1) IL50911A (fi)
KE (1) KE3286A (fi)
NL (1) NL189297C (fi)
NO (1) NO153298C (fi)
NZ (1) NZ182630A (fi)
PH (1) PH16714A (fi)
PL (1) PL110937B1 (fi)
PT (1) PT65865B (fi)
SE (1) SE427841B (fi)
SG (1) SG10983G (fi)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1593524A (en) * 1976-11-19 1981-07-15 Merck & Co Inc 1-carba-2-penem-3-carboxylic acids
DK170778A (da) * 1977-05-05 1979-01-15 Merck & Co Inc Fremgangsmaade til fremstilling af n-alkyl-n-iminomethyl-derivater af thienamycin
US4232030A (en) * 1977-09-15 1980-11-04 Merck & Co., Inc. Substituted N-methylene derivatives of thienamycin sulfoxide and sulfone
DK153486C (da) * 1978-07-03 1988-11-28 Merck & Co Inc Analogifremgangsmaade til fremstilling af krystallinsk n-formimidoyl-thienamycin-monohydrat
EP0044170A1 (en) * 1980-07-11 1982-01-20 Beecham Group Plc Beta-lactam antibiotics, their preparation and use
CA2089261A1 (en) * 1990-08-30 1992-03-01 John F.W. Keana Substituted amidines having high binding to the sigma receptor and the use thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1004670A (en) * 1963-04-23 1965-09-15 Beecham Res Lab Penicillins
GB1348985A (en) * 1970-06-16 1974-03-27 Merck & Co Inc Esters of cephalosporin compounds
US3950357A (en) * 1974-11-25 1976-04-13 Merck & Co., Inc. Antibiotics

Also Published As

Publication number Publication date
FI62306B (fi) 1982-08-31
IL50911A (en) 1981-01-30
GR62072B (en) 1979-02-20
IE44433L (en) 1977-05-21
HU180865B (en) 1983-04-29
FR2332012B1 (fi) 1978-11-17
AU1964776A (en) 1978-05-25
KE3286A (en) 1983-06-17
DE2652679A1 (de) 1977-06-02
NO153298B (no) 1985-11-11
PT65865B (en) 1978-10-12
DD127742A5 (de) 1977-10-12
NZ182630A (en) 1979-07-11
GB1570990A (en) 1980-07-09
SE7612963L (sv) 1977-05-22
DK157401C (da) 1990-05-21
DK523576A (da) 1977-05-22
SG10983G (en) 1983-12-16
PL110937B1 (en) 1980-08-30
DE2652679C2 (fi) 1990-03-01
BG34037A3 (en) 1983-06-15
FI62306C (fi) 1982-12-10
NO763958L (fi) 1977-05-24
PL193809A1 (pl) 1978-01-16
EG12261A (en) 1978-12-31
DK157401B (da) 1990-01-02
FI763308A (fi) 1977-05-22
HK29683A (en) 1983-08-26
IE44433B1 (en) 1981-12-02
NL189297B (nl) 1992-10-01
NL189297C (nl) 1993-03-01
NO153298C (no) 1986-02-19
PH16714A (en) 1984-01-25
CA1083577A (en) 1980-08-12
CH633800A5 (en) 1982-12-31
SE427841B (sv) 1983-05-09
ATA863476A (de) 1980-01-15
IL50911A0 (en) 1977-01-31
FR2332012A1 (fr) 1977-06-17
NL7612939A (nl) 1977-05-24
AU512383B2 (en) 1980-10-09
ES453501A1 (es) 1978-03-01
CH632510A5 (en) 1982-10-15
PT65865A (en) 1976-12-01

Similar Documents

Publication Publication Date Title
AT360005B (de) Verfahren zur herstellung von neuen sulfonyl- benzimidazolderivaten
AT359657B (de) Verfahren zur herstellung von neuen prostan- derivaten
AT362085B (de) Verfahren zur herstellung von neuen 16- -dehydroandrostan-derivaten
AT344163B (de) Verfahren zur herstellung von neuen oxadiazolinon-derivaten
AT360006B (de) Verfahren zur herstellung von neuen thiazolinylbenzimidazolderivaten
AT357274B (de) Verfahren zur herstellung von neuen derivaten des 20,21-dinoreburnamenins
AT347453B (de) Verfahren zur herstellung von neuen 5-phenyl- oxazolidinon-2-derivaten
AT358168B (de) Verfahren zur herstellung von neuen substituierten n-methylenderivaten des thienamycins
ATA501676A (de) Verfahren zur herstellung von neuen naphthalinderivaten
AT354650B (de) Verfahren zur herstellung von neuen bicyclo- heptenderivaten
AT357698B (de) Verfahren zur herstellung von neuen octapeptid- derivaten
AT358202B (de) Verfahren zur herstellung von neuen derivaten des 9-chlorprednisolons
AT348677B (de) Verfahren zur herstellung von neuen thiadiazolyl-derivaten der 7-acylamido-3-cephem-4-carbonsaeure
AT345278B (de) Verfahren zur herstellung von neuen oxazolderivaten
AT343291B (de) Verfahren zur herstellung von neuen quartaren xanthinylalkyl-nortropinderivaten
AT365567B (de) Verfahren zur herstellung von neuen derivaten des s-carboxybenzyl-l-cysteins
AT353957B (de) Verfahren zur herstellung von neuen cephalos- porinderivaten
AT350555B (de) Verfahren zur herstellung von neuen additions- salzen von thiazol-5-methanolderivaten
AT345818B (de) Verfahren zur herstellung von neuen oxazolderivaten
ATA504978A (de) Verfahren zur herstellung von neuen thienothiazinderivaten
AT356813B (de) Verfahren zur herstellung von neuen penicillin- derivaten
ATA706679A (de) Verfahren zur herstellung von neuen derivaten des 4-hydroxi-thiazolidin-2-thions
AT373603B (de) Verfahren zur herstellung von neuen derivaten des 9-chlorprednisolons
ATA796779A (de) Verfahren zur herstellung von neuen derivaten des 9-chlorprednisolons
ATA796979A (de) Verfahren zur herstellung von neuen derivaten des 9-chlorprednisolons

Legal Events

Date Code Title Description
ELA Expired due to lapse of time
EZF Grant of a certificate of protection

Free format text: SZ 102/1994, 19941220, EXPIRES:20000824

SZA Application filed for a certificate of protection

Free format text: SZ 102/1994, 19941220